Surveys uncovers findings pre- and post-pandemic
New company will focus on developing bispecific antibodies for rare bleeding disorders
British drugmaker will acquire Alexion for approximately $39bn
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
David Malcolm Thomas (“Dave”) was born to be a great doctor. He trained at Cambridge and St Thomas’ […]
